Modification of cord blood IL-6 production with IgM enriched human immunoglobulin in term and preterm infants

Cytokine

Volumn 26, Issue 1, 2004, Pages 25-29

  Dembinski, J ^a,b   Martini, R ^a   Behrendt, D ^a   Bartmann, P ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Bethesda Hospital   (Netherlands)

Author keywords

Cord blood; Immunoglobulin; Interleukin 6; Interleukin 8; Lipopolysaccharide

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ARTICLE; BLOOD CULTURE; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; GESTATIONAL AGE; HUMAN; INCUBATION TIME; NORMAL HUMAN; PREMATURITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

CELLS, CULTURED; CESAREAN SECTION; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN M; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES;

EID: 1542328166     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.12.005     Document Type: Article

References (34)

1. Zhang G., Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res. 6:2000;453-457.
2. Mukaida N., Ishikawa Y., Ikeda N., Fujioka N., Watanabe S., Kuno K., et al. Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukoc Biol. 59:1996;145-151.
3. Leon L.R. Invited review: cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol. 92:2002;2648-2655.
4. Jones T.H., Kennedy R.L. Cytokines and hypothalamic-pituitary function. Cytokine. 5:1993;531-538.
5. Atta-ur-Rahman, Harvey K., Siddiqui R.A. Interleukin-8: an autocrine inflammatory mediator. Curr Pharm Des. 5:1999;241-253.
6. Kramer B.W., Moss T.J., Willet K.E., Newnham J.P., Sly P.D., Kallapur S.G., et al. Dose and time response after intraamniotic endotoxin in preterm lambs. Am J Respir Crit Care Med. 15:(164):2001;982-988.
7. Yoon B.H., Romero R., Jun J.K., Park K.H., Park J.D., Ghezzi F., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 177:(4):1997;825-830.
8. Munshi U.K., Niu J.O., Siddiq M.M., Parton L.A. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol. 24:(5):1997;331-336.
9. Duggan P.J., Maalouf E.F., Watts T.L., Sullivan M.H., Counsell S.J., Allsop J., et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet. 17:2001;1699-1700.
10. Heep A., Behrendt D., Nitsch P., Fimmers R., Bartmann P., Dembinski J. Increased serum levels of interleukin-6 are associated with severe intraventricular hemorrhage in extremely premature infants. Arch Dis Child Fetal Neonatal Ed. 88:2003;F501-F504.
11. Barclay G.R. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog Clin Biol Res. 392:1995;263-272.
12. Ross C., Svenson M., Nielsen H., Lundsgaard C., Hansen M.B., Bendtzen K. Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood. 15:(90):1997;2376-2380.
13. Strutz F., Heller G., Krasemann K., Krone B., Muller G.A. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med. 25:1999;435-444.
14. Nachbaur D., Herold M., Gachter A., Niederwieser D. Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin). Immunology. 94:1998;279-283.
15. Youd M.E., Ferguson A.R., Corley R.B. Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur J Immunol. 32:2002;2328-2337.
16. Oesser S., Schulze C., Seifert J. Protective capacity of a IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Res Exp Med (Berl). 198:(6):1999;325-339.
17. Dembinski J., Behrendt D., Reinsberg J., Bartmann P. Endotoxin- stimulated production of IL-6 and IL-8 is increased in short-term cultures of whole blood from healthy term neonates. Cytokine. 21:(18):2002;116-119.
18. Dembinski J., Behrendt D., Martini R., Heep A., Bartmann P. Modulation of pro- and anti-inflammatory cytokine production in very preterm infants. Cytokine. 21:2003;200-206.
19. Darville T., Tabor D., Simpson K., Jacobs R.F. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-alpha production in vitro. Pediatr Res. 35:1994;397-403.
20. Xu C., Poirier B., Van Huyen J.P., Lucchiari N., Michel O., Chevalier J., et al. Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases. Am J Pathol. 153:(4):1998;1257-1266.
21. Wolf H.M., Hauber I., Gulle H., Samstag A., Fischer M.B., Ahmad R.U., et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Clin Exp Immunol. 105:(3):1996;537-543.
22. Andersson J., Skansen-Saphir U., Sparrelid E., Andersson U. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol. 104:(Suppl 1):1996;10-20.
23. Dembinski J., Behrendt D., Heep A., Dorn C., Reinsberg J., Bartmann P. Cell-associated interleukin-8 in cord blood of term and preterm infants. Clin Diagn Lab Immunol. 9:2002;320-323.
24. Cavaillon J.M., Munoz C., Fitting C., Misset B., Carlet J. Circulating cytokines: the tip of the iceberg? Circ Shock. 38:1992;145-152.
25. Gawad K.A., Schneider C., Brinken B., Huflander A., Diederichs B., Mack D., et al. Anti-TNF antibody treatment has no positive effect on survival in a model of pneumococcal sepsis in pigs. J Invest Surg. 14:2001;291-297.
26. Gallagher J., Fisher C., Sherman B., Munger M., Meyers B., Ellison T., et al. A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome. Intensive Care Med. 27:2001;1169-1178.
27. Reinhart K., Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med. 29:(Suppl):2001;S121-S125.
28. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 1:(1):2001;1.
29. Halliday H.L. The effect of postnatal steroids on growth and development. J Perinat Med. 29:2001;281-285.
30. Sandberg K., Fasth A., Berger A., Eibl M., Isacson K., Lischka A., et al. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr. 137:2000;623-628.
31. Weisman L.E., Stoll B.J., Kueser T.J., Rubio T.T., Frank C.G., Heiman H.S., et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr. 125:1994;922-930.
32. Amato M., Huppi P., Imbach P., Llauto A., Burgi W. Immunoglobulin subclass concentration in preterm infants treated prophylactically with different intravenous immunoglobins. Am J Perinatol. 12:1995;306-309.
33. Amato M., Huppi P., Imbach P., Llanto A., Burgi W. Serial IgG and IgM serum levels after infusion of different Ig-preparations (IgG or IgM-enriched) in preterm infants. Pediatr Allergy Immunol. 4:1993;217-220.
34. Amato M., Markus D., Huppi P., Imbach P. Immunoglobulin serum levels in very low birth weight infants treated with different intravenous preparations. Ann Hematol. 63:1991;210-213.